MMDCF - Definium Therapeutics, Inc.
$—
0 n/a
Share volume: —
Last Updated: —
Pharmaceutical Products/Medicinal Chemicals:0.37%
Previous close—
Chg—
Chg%—%
-------
No prices for this period.
To see more than 2 years history Buy Premium
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | 06-30-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
| Announced | 11-07-2024 | — | — | 07-31-2025 | 11-06-2025 | — | 05-07-2026 | — | |
| Filed | 11-07-2024 | — | — | 07-31-2025 | 11-06-2025 | — | 05-07-2026 | 08-06-2026 | |
| Total revenue | 0.000 | — | 0.000 | 0.000 | 0.000 | — | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | — | 0.000 | 0.000 | 0.000 | — | 0.000 | 0.000 | |
| +Gross profit | 0.000 | — | 0.000 | 0.000 | 0.000 | — | 0.000 | 0.000 | |
| Operating expenses | 24.792 M | 32.462 M | 32.159 M | 40.903 M | 45.669 M | 47.578 M | 59.220 M | 75.077 M | |
| Selling general and admin | 7.604 M | 10.703 M | 8.802 M | 11.094 M | 14.691 M | 14.057 M | 17.736 M | 26.412 M | |
| Research and development | 17.188 M | 21.759 M | 23.357 M | 29.809 M | 30.978 M | 33.521 M | 41.484 M | 48.665 M | |
| +Total expenses | 24.792 M | 32.462 M | 32.159 M | 40.903 M | 45.669 M | 47.578 M | 59.220 M | 75.077 M | |
| Operating income | -24.792 M | -32.462 M | -32.159 M | -40.903 M | -45.669 M | -47.578 M | -59.220 M | -75.077 M | |
| Ebit | -16.464 M | -37.364 M | -25.179 M | -43.180 M | -68.253 M | -52.659 M | -79.310 M | -161.340 M | |
| +Pretax income | -13.684 M | -34.741 M | -23.348 M | -42.744 M | -67.265 M | -50.436 M | -77.098 M | -158.986 M | |
| Income tax | — | — | — | — | — | — | — | — | |
| +Net income basic | -13.684 M | -34.741 M | -23.348 M | -42.744 M | -67.265 M | -50.436 M | -77.098 M | -158.986 M | |
| +Net income | -13.684 M | -34.741 M | -23.348 M | -42.744 M | -67.265 M | -50.436 M | -77.098 M | -158.986 M |